Crossroads Treatment Centers, based in Greenville, S.C., has recently unveiled a new treatment option for individuals recovering from opioid use disorder (OUD): injectable medications. This development marks a significant shift in the way treatment is administered, especially for those who face challenges with adhering to daily oral medications.
Dr. James Stephen, Chief Medical Officer at Crossroads, highlighted the benefits of this innovative approach. "These safe, effective, and powerful medications continue to transform the treatment of opioid use disorder," he stated. The injectable form of buprenorphine provides a consistent and reliable method for delivering steady doses of medication, which is critical in helping patients manage their recovery and lead productive lives.
The injectable medications are administered on a weekly or monthly basis, which ensures stable levels of buprenorphine in the bloodstream. This method significantly reduces opioid cravings and withdrawal symptoms, making it a more effective treatment option. According to the Substance Abuse and Mental Health Services Administration (SAMHSA), 6.1 million people were affected by OUD in 2022, but only 18.3 percent received medication-assisted treatment (MAT). Crossroads aims to address this gap by providing more accessible treatment options.
Injectable medications are a part of a broader, comprehensive treatment plan. They are designed to be used alongside counseling, behavioral therapies, and other support services tailored to each patient's specific needs. The injectable approach offers several advantages:
1. Reduced Risk of Abuse and Tampering: Compared to oral medications, injectable forms are less prone to misuse.
2. Greater Convenience: With fewer required office visits, patients have more flexibility and can better manage their schedules.
3. Enhanced Engagement in Treatment: Patients can focus more on their counseling and support services instead of daily medication management.
Crossroads Treatment Centers has been a pioneer in substance use disorder treatment since 2005. With over 100 centers across nine states, the organization comprises a dedicated team of doctors, nurse practitioners, counselors, and professionals. Their mission is to provide the most accessible and highest quality treatment options to combat the growing substance use epidemic.
The organization creates individualized treatment plans that incorporate evidence-based medication-assisted treatment and behavioral health therapies. These comprehensive plans are designed to help individuals with substance use disorder find their path to recovery, leading to significantly improved lives for the patients, their families, and their communities.
How to obtain the latest research advancements in the field of biopharmaceuticals?
In the Synapse database, you can keep abreast of the latest research and development advances in drugs, targets, indications, organizations, etc., anywhere and anytime, on a daily or weekly basis. Click on the image below to embark on a brand new journey of drug discovery!